Literature DB >> 27904741

Albiglutide-induced pancreatitis.

Nidhi Jain1, Malvi Savani2, Manyoo Agarwal2, Christopher W Sands2.   

Abstract

Entities:  

Year:  2016        PMID： 27904741      PMCID： PMC5117154          DOI： 10.1177/2042098616667352

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  14 in total

Review 1.  Adverse Effects of GLP-1 Receptor Agonists.

Authors:  Theodosios D Filippatos; Thalia V Panagiotopoulou; Moses S Elisaf
Journal:  Rev Diabet Stud       Date:  2015-02-10

2.  Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study.

Authors:  Reimar Wernich Thomsen; Lars Pedersen; Niels Møller; Johnny Kahlert; Henning Beck-Nielsen; Henrik Toft Sørensen
Journal:  Diabetes Care       Date:  2015-01-29       Impact factor: 19.112

Review 3.  Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.

Authors:  Carlo B Giorda; Carlotta Sacerdote; Elisa Nada; Lisa Marafetti; Ileana Baldi; Roberto Gnavi
Journal:  Endocrine       Date:  2014-08-22       Impact factor: 3.633

Review 4.  Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.

Authors:  Jennifer M Trujillo; Wesley Nuffer
Journal:  Ann Pharmacother       Date:  2014-08-18       Impact factor: 3.154

5.  Drug induced acute pancreatitis: does it exist?

Authors:  Scott Tenner
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

6.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

7.  Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.

Authors:  S Montilla; G Marchesini; A Sammarco; M P Trotta; P D Siviero; C Tomino; D Melchiorri; L Pani
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-10-06       Impact factor: 4.222

Review 8.  Novel Therapeutic Approaches in Diabetes.

Authors:  Baptist Gallwitz
Journal:  Endocr Dev       Date:  2016-01-19

Review 9.  A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond.

Authors:  Lalita Prasad-Reddy; Diana Isaacs
Journal:  Drugs Context       Date:  2015-07-09

10.  Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.

Authors:  Mark M Smits; Lennart Tonneijck; Marcel H A Muskiet; Trynke Hoekstra; Mark H H Kramer; Indra C Pieters; Djuna L Cahen; Michaela Diamant; Daniël H van Raalte
Journal:  BMJ Open       Date:  2015-11-19       Impact factor: 2.692
View more
  1 in total

1.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.